New Mega Health-Care Trio Offers Opportunity For Digital Sector
Executive Summary
A new independent health-care company created by Amazon, Berkshire Hathaway and JPMorgan will put an emphasis on using technology to "simplify" health care. That is music to the ears of digital-health firms.
You may also be interested in...
Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
Into 2019: Intelligent Innovation's Role In The Shape Of Medtech Things To Come
Brexit, the "Implant Files" and the new EU regulations – however large they loom at present, they will in time be seen as mere tactical challenges for a global medtech industry working hard to ensure that it is ready for the massive health-care delivery and service-oriented changes to come. Preparing for the future and maximizing current market penetration – in the UK, the EU and beyond – were key themes at UK HealthTech 2018, held in Cardiff, Wales.
Diabetes Care A Prime Target For Amazon
Amazon's recent partnership with the Arcadia Group to supply blood glucose strips and meters under the new brand name Choice is another move by the retail giant to disrupt the health-care sector using the path of least resistance.